This retrospective cohort study included 202 patients with unresectable pancreatic cancer. The investigators developed a machine-learning model using 1,130 CT radiomics features from the primary lesion combined with clinical predictors (age, sex, CA19-9). The primary outcome was overall survival (OS).
For the entire cohort, the median overall survival (mOS) was 20.3 months. The model's performance for predicting OS at specific time points showed an area under the receiver operating characteristic curve (AUC) of 0.804 for 1-year OS, 0.812 for 2-year OS, and 0.794 for 3-year OS.
Safety and tolerability data were not reported for this retrospective analysis. Key limitations include the single-center, retrospective design and lack of an external validation cohort. The study does not report follow-up duration, comparator groups, or statistical significance measures.
While the model shows promising discriminatory ability, the evidence is preliminary. Clinicians should interpret these results cautiously, as the findings require prospective validation before any clinical application.
View Original Abstract ↓
BackgroundWe aimed to develop an interpretable radiomics–clinical model to predict overall survival (OS) in unresectable pancreatic cancer (PC).MethodsIn this retrospective cohort, 202 patients with unresectable PC were enrolled. A total of 1,130 radiomics features were extracted from a region of interest encompassing the largest primary lesion using 3D-Slicer. Least absolute shrinkage and selection operator (LASSO)-selected features associated with OS were used to construct a radiomics risk score (RS). Independent clinical predictors were identified through stepwise Cox regression. A nomogram integrating RS with independent clinical predictors was built.ResultsMedian OS (mOS) for the entire cohort was 20.3 months. From 1,130 baseline CT radiomics features, LASSO retained 12 prognostic descriptors, which were linearly combined to compute a radiomics RS. Stepwise Cox regression identified age, sex, and CA19-9 as independent clinical predictors. A nomogram integrating RS with these variables was constructed in the training set. In the validation set, the area under the receiver operating characteristic curve (AUC) reached 0.804, 0.812, and 0.794 for 1-, 2-, and 3-year OS, respectively.ConclusionAn interpretable radiomics–clinical nomogram provided accurate survival prediction in unresectable pancreatic cancer.